Investigation Of Small Molecular Substances As Potential Biomarkers For Discrimination Of Gastric Tumor

Onco Targets Ther. 2019 Oct 17:12:8587-8594. doi: 10.2147/OTT.S221589. eCollection 2019.

Abstract

Background: Gastric tumor (GT) is associated with high morbidity and mortality, with surgery among the most effective treatment methods. Accurate interoperative determination of the tumor margin is crucial.

Methods: In this study, using internal extractive electrospray ionization-MS, mass spectral data of GT and gastric normal (GN) tissues from 36 patients were collected.

Results: In positive ion detection mode, the relative abundances of m/z 132, 147, 170, and 175 were increased, while the relative abundances of m/z 55, 83, 154, and 203 were decreased in GT tissue. Using partial least squares analysis, the mass spectral data of GT and GN tissues were discriminated, and differential ions (P≤0.01), including m/z 55, 83, 154, 170, and 203, were obtained from loading plots. After receiver operating characteristic curve analysis, peaks at m/z 83 and 203 showed high accuracy for distinguishing GT from GN tissue. These two peaks were then preliminarily attributed to 5-aminoimidazole and serylproline, respectively, which might be useful molecular biomarkers associated with GT development.

Conclusion: Further investigations of the functions of 5-aminoimidazole and serylproline might provide a better understanding of the underlying mechanisms involved in GT.

Keywords: MS; biomarkers; gastric tumor; mass spectrometry; tumor margin.